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Neopterin in In addition to viral infections, malignant disorders, autoimmune diseases, and allograft 
rejection episodes, neopterin increases in older people where it is found to be predictive of overall 
mortality. Thus, the serum concentrations of this biomarker of systemic immune and inflammation 
activation, were measured in a small cohort of Sardinian middle-aged, older adults and 
centenarians. There was a significant positive correlation between neopterin concentrations and age 
with the subjects in the 95-year-old group with the highest values. Notably, the group of 
centenarians had neopterin values comparable to those of 80- and 90-year-old groups, and 
significantly lower than that of 95-year-old group. This suggests a decreased 
monocyte/macrophage-mediated immune activation and an apparently preserved immune status in 
centenaries centenarians. 
 




















The alteration in the immune response with advancing age, i.e., the immunosenescence (IS), has 
been well documented in humans and contributes to the increased morbidity and mortality in the 
older population (Ginaldi et al., 2001). IS may lead, in fact, to a decrease in the immune 
competence resulting in an increased susceptibility to infectious diseases and a poor response to 
immunization (Wu and Meydani, 2008). Aside from immunodeficiency, old age is also 
characterized by a greater susceptibility to autoimmune responses and by a persistent systemic 
inflammatory state (Oishi and Manabe, 2016) termed inflammaging (IF) (Franceschi and Campisi, 
2014). The latter is characterized by elevated concentrations of proinflammatory cytokines, clotting 
factors, and acute phase reactants (Shaw et al., 2013;). Although IF is usually subclinical and of 
low grade, it leads to long-term tissue degeneration involved in the pathogenesis of several non-
communicable metabolic (Oishi and Manabe, 2016), neurodegenerative (Licastro et al., 2003), 
neoplastic (Oishi and Manabe, 2016), cardiovascular (Ridker et al., 2000), and autoimmune 
(Capuron et al., 2014) age-related diseases. The chronic activation of the immune system, proposed 
as a likely causal agent in such process, appears to be linked to the evolutionary, unpredicted, 
antigenic load caused by clinical and subclinical infections as well as the exposure to noninfective 
antigens (Baylis et al., 2013). Persistent exposure to antigens causes, in fact, a lifelong, chronic 
antigenic stress leading to adaptative processes resulting in an unspecific activation of macrophages 
and immunity cells that exhibit a senescent phenotype (Straub, 2015). The continuous 
proinflammatory load would induce a chronic immune stimulation, with an overproduction of 
activated cells and an overexpression of apoptosis-linked receptors in lymphocytes (Straub, 2015). 
The senescent cells, in turn, would become less prone to spontaneous apoptosis, thus filling the 
immunological space in peripheral lymphoid organs (Straub, 2015). This results in a state of 
impaired immune response and concomitant upregulation of the inflammatory response (Fulop et 
al., 2016). Older adults in the ‘old-old’ subgroup, particularly centenarians, appear to escape from 

















identification of measurable circulating biomarkers of immune activation status in older adults 
might be useful to identify specific genotypic and/or phenotypic patterns associated with healthy 
ageing, and to enhance disease risk stratification. Neopterin is a pyrazino-pyrimidine compound 
synthesized by the principal cell population of the innate immune system (macrophages) in 
response to one of the principal cytokines regulating adaptive immune response (interferon-γ, IFN-
γ), produced by activated type 1 helper T-cells (Th1) (Hamerlinck, 1999; Melichar et al., 2006). 
Neopterin concentrations in human biological fluids are a sensitive marker of systemic immune and 
inflammatory activation (Fuchs et al., 1992; Murr et al., 2002), and have been shown to increase 
during viral infections, malignant disorders, autoimmune diseases, and allograft rejection episodes 
(Murr et al., 2009). Moreover, as neopterin production is also associated with increased production 
of reactive oxygen species and with low serum concentrations of antioxidants such as alpha-
tocopherol (Murr et al., 2009), it can be also used as a marker of reactive oxygen species formed by 
the activated cellular immune system (Murr et al., 1999). With this background in mind, we aimed 
to investigate the immune activation status in different age groups within a Sardinian older 
population that included centenarians, by measuring the plasma concentrations of neopterin. We 
tested the hypothesis that the concentrations of neopterin are relatively lower in centenarians, 
reflecting a decreased cellular immune activation in this age group.  
 
2. Material and methods 
2.1 Study Population 
The participants were recruited within the framework of a wider research project for the discovery 
of molecular and genetic/epigenetic signatures underlying resistance to age-related diseases and 
comorbidities. Eligible participants were randomly selected from the electoral roll within the 
provinces of Sardinia region (Italy) and contacted by telephone by a trained study recruitment 
officer. Criteria for inclusion in the study were age, born and living in Sardinia, not being 

















of 149 subjects, 48 males, and 101 females, aged 60 to 104 years and residing in different 
municipalities of the Sardinia region (Italy), were enrolled according to the characteristic male-to-
female sex ratio around 1:2.7 observed among Sardinian centenarians (Passarino et al., 2002). The 
study sample was then grouped into 5 age categories: 60-year-old (mean age (range) 60.7 (60-62) 
±0.7 years, n=31), 80-year-old (mean age (range) 81.3 (80-89) ±2.6 years, n=32), 90-year-old 
(mean age (range) 91.2 (90-94) ±1.5 years, n=37), 95-year-old (mean age (range) 95.9 (95-99) ±1.1 
years, n=23), and 100-year-old (mean age (range) 100.9 (100-104) ±1.2 years, n=27). A self-
administered An interview questionnaire was used to collect detailed information about existing 
chronic medical conditions and life-style habits of the participants. The interview was conducted 
after the blood sampling, and the questionnaire was filled out by the observer based on the answers 
given by the participants. All subjects were able to answer without the help of third-parties. 
Subjects in the 60-year-old group had no known history of chronic diseases whereas about 60% of 
participants in the other groups reported one or more medical conditions such as hypertension 
(78.8%), diabetes (12.2%), hypercholesterolemia (10.1%), asthma (7.1%), and hearth failure 
(4.1%). Most of the subjects were either non-smokers or former smokers, and only 2.9% were 
current smokers. Non-drinkers, former drinkers and current drinkers represented the 25.7%, 42.9%, 
and 31.4% of the study population, respectively. Ethics approval to conduct the study was granted 
by the University of Sassari. The study was performed in accordance with the guidelines of the 
Declaration of Helsinki. All participants gave written informed consent before entering in the 
study. 
 
2.2 Blood sample collection and biochemical analyses 
Fasting blood samples were obtained in the morning after an approximately ten-hour overnight and 
anyway within 9:30 am. Blood samples were Samples were collected by venipuncture into EDTA-
treated plain tubes or tubes without anticoagulant and centrifuged at 4 °C and 3,000×g for 10 min 

















Without previous freeze-thaw cycles, neopterin was measured by an ultra-performance liquid 
chromatographer (UPLC) with fluorescence detection as described by Carru et al. (2004) with 
minor adjustments. Briefly, 50 µL of a 15% (w/v) trichloroacetic acid solution were added to 100 
µL of a standard or plasma sample to precipitate the proteins, and centrifuged at 10,600×g for 10 
min at 4 °C. A 20 µL-volume of clear supernatant was injected into UPLC and the ultra-
performance liquid chromatography was carried out at room temperature on a 200 mm x 5 mm 
reversed-phase Waters Spherisorb ODS/2 5 µm column at a flow rate of 1.2 mL min
-1
 with 
water:acetonitrile (98:2) as the mobile phase. Neopterin was detected making use of its natural 
fluorescence at an excitation wavelength of 353 nm and an emission wavelength of 438 nm. Plasma 
creatinine and glutathione (GSH) were assayed as described by Zinellu et al. (2004, 2003) as 
indexes of renal function and of the oxidative stress, respectively. Serum folate and vitamin B12 
were measured by using an IMX Analyzer (Abbott Labs, Abbott Park, IL, USA) as indexes of 
nutritional status (Green, 2011). 
 
2.3 Statistical 
Data were checked for normality of distribution using the Kolmogorov-Smirnov test and were 
presented either as mean±SD or median and interquartile range (IQR) if data distribution was 
skewed. Depending on the normality of the distribution of the variables, associations between 
continuous variables were assessed using Pearson or Spearman rank correlation coefficients as 
appropriate. Differences between groups were assessed by ANOVA or Kruskal-Wallis test as well 
as by independent t-test or Mann-Whitney test (independent samples) as appropriate. When a 
significant difference was observed, the pairwise comparison of subgroups was performed by a 
Student-Newman-Keuls test for ANOVA or according to Conover (1999) for the Kruskal-Wallis 
test. Jonckheere-Terpstra trend test was performed to check if medians were ordered (increase or 
decrease) according to the order of the qualitative factor. Partial correlation analysis after log10 

















different variables to plasma neopterin concentrations. Chi-squared test was used to test for 
significant differences in the frequency of clinical status between age groups. A two-sided P value 
of 0.05 was chosen as the cut-off for statistical significance. Statistical analyses were performed 
using MedCalc Statistical Software for Windows, version 17.5.5 64 bit (MedCalc Software bvba, 
Ostend, Belgium). 
 
 3. Results 
Subjects in the 60-year-old group had no known history of chronic diseases whereas about 60% of 
participants in the other groups reported one or more medical conditions such as hypertension 
(78.8%), diabetes (12.2%), hypercholesterolemia (10.1%), asthma (7.1%), and hearth failure 
(4.1%). The prevalence of chronic disease in centenarians was lower than other groups, although 
this difference was not statistically significant (66% vs. 75%, chi-squared = 0.0117, P= 0.91). Most 
of the subjects were either non-smokers or former smokers, and only 2.9% were current smokers. 
Non-drinkers, former drinkers and current drinkers represented the 25.7%, 42.9%, and 31.4% of the 
study population, respectively. Table 1 outlines the biochemical parameters considered in the study 
population. The distribution of plasma neopterin concentration was skewed, with slightly more than 
half of the participants (52%) having values ranging between 10 and 30 nM. Median neopterin 
concentration was 20.35 (IQR 11.7-32.2) nM, and there were no significant gender-related 
differences (females 19.09 (IQR 11.2-30.7) nM vs. males 22.4 (IQR 13.1-33.1) nM, P=0.54). There 
was a significant positive correlation between neopterin concentrations and age (Spearman rank 
correlation coefficient = 0.27; P=0.0008). Partial correlation analysis by using gender and the 
concentrations of creatinine, folate, glutathione and vitamin B12 as covariates, strengthen the 
independent association between age and plasma neopterin concentrations (P=0.0026). However, as 
displayed in figure 1, which shows a local regression smoothing trendline, a trend towards lower 
neopterin concentrations was observed with age above ~92 years. As displayed in figure 2, 

















analysis for pairwise comparisons (table 2) shows a significant age-associated increase in neopterin 
concentrations up to the 95-year-old group (95.9±1.1 years). However, in the 100-year-old group 
neopterin concentrations were significantly lower than those of the 95-year-old group. The trend to 
lower neopterin concentrations in the 100-year-old cluster vs. the 95-year-old group, assessed by 
Jonckheere-Terpstra trend test, was significant at P=0.024 (Figure 3). The median creatinine 
concentration in the whole study population was 0.9 (0.8-1.2) mg/dL, and there was a significant 
gender-related difference (females 0.8 (IQR 0.7-1.0) mg/dL vs. males 1.1 (IQR 0.9-1.5) mg/dL, P < 
0.0001). Except for the 60-years-old group no significant difference in creatinine concentrations 
among the other age groups was observed. The median GSH concentration in the whole study 
group was 3.9 (IQR 2.7-5.4) µM, and there were no significant gender-related differences (females 
4.0 (IQR 2.8-5.6) µM vs. males 3.6 (IQR 2.4-5.1) µM, P = 0.25). GSH concentrations showed a 
significant trend to increase with advancing age, with the centenarians showing the highest 
concentrations. However, no significant differences between GSH concentrations was observed 
among the 90-, 95-, and 100-years-old groups. Median values of serum folic acid in the whole 
study population were 5.6 (IQR 4.2-7.5) nM, and they were significantly higher in females than 
males (females 6.0 (IQR 4.3-8.3) nM vs. males 4.8 (IQR 4.0-6.5) nM, P = 0.04). There was no 
significant difference in serum folic acid concentrations among the 90-, 95-, and 100-years-old 
groups. Median concentrations of vitamin B12 were 373 (IQR 286-481) pg/mL, and they did not 
differ between males and females (females 395 (IQR 288-544) pg/mL vs. males 335 (IQR 277-429) 
pg/mL, P = 0.25). Moreover, no difference between the five age groups was observed. Considering 
the neopterin mean values for the 95-years old group and centenarians observed in our study 
(31.8±15.8 nM vs. 22.5±13.1 nM) and a type I error – alpha of 0.05, a post-hoc sample size to have 
a power of 80%, 90%, 99.95%, and 99.99% was, respectively, 18, 23, 28, and 39 subjects. In our 
study, the sample size in the 95-years old group and the centenarians was, respectively, 23 and 27 



















The measurement of neopterin in body fluids allows to sensitively monitor the degree of immune 
activation (Fuchs et al., 1992) and, therefore, of the immune processes that appear to underlie key 
age-related diseases affecting life expectancy in older adults. In this analysis of Sardinian older 
adults, the whole group of participants (mean age 85.25±14.20 years) had a median neopterin value 
of 20.35 (IQR 11.66-32.23) nM. Although slightly greater than the average levels reported by other 
authors, these values are consistent with the upper limits of normal reported by Reibnegger et al. 
(1988) (19.0 nM above 75 years). As reported in earlier studies (Diamondstone et al., 1994; 
Schennach et al., 2002), we also found that plasma neopterin concentrations significantly correlate 
with age, suggesting increased monocyte/macrophage-mediated immune activation with advancing 
age. Indeed, there is good evidence that the immune system in aging acts in a proinflammatory 
fashion (Franceschi et al., 2000) and, in this sense, increased concentrations of proinflammatory 
markers including neopterin have been well documented in healthy older people (Catania et al., 
1997; Myśliwska et al., 1998; Murr et al., 2004). On the other hand, a proinflammatory 
environment might partially compensate for the declining T-cell function detected in old age 
(Baggio et al., 1998; Franceschi et al., 2000). The five age clusters selected for this study showed 
significantly different values for plasma neopterin and, as already observed by Aulitzky et al. 
(1988), there was no statistically significant sex-related difference. As expected for healthy 
subjects, the 60-year-old group had the lower neopterin levels, followed by 80-, 90-, and 95-year-
old groups. This was compatible with their stated health status, as about 60% of the individuals of 
the latter groups received a physician diagnosis of at least one chronic medical condition. It should 
be noted, in addition, that the clinical status of the subjects might be even underestimated as many 
geriatric conditions, including common ones such as sarcopenia and asthma are often 
underrecognized by physicians (Fielding et al., 2011; Gillman and Douglass, 2012). On the other 
hand, it is also possible that in some apparently healthy subjects, the pathological process may have 

















status that was comparable to that of other age groups, had neopterin values comparable to those of 
80- and 90-year-old groups, and significantly lower than that of 95-year-old group. The similarities 
in the prevalence of chronic disease burden between the centenarians and the other study groups do 
not explain the reported difference in neopterin concentrations. The latter are also This is unlikely 
to be secondary to changes in renal function, as described by other authors (Lhee et al., 2006). 
Although significantly lower in the 60-years-old group and despite it does not accurately reflect 
changes in renal function in older people as muscle mass and dietary protein intake affect its levels, 
serum creatinine concentrations, in fact, did not differ significantly among the 80-, 90-, 95-, and 
100-years-old groups. On these bases, therefore, a different nutritional state among of the 
individuals in these age groups can be also excluded and, in this sense, markers of nutritional state, 
i.e. serum folic acid and vitamin B12 concentrations, were not dissimilar in the 90, 95-, and 100-
years-old groups. From an immunity point of view, therefore, this finding reveals that centenarians 
seem younger than their age, in accordance with earlier observations reporting that immune 
responses in healthy centenarians were closer to those observed in younger adults than those in 70-
year-old subjects (Alonso-Fernandez et al., 2008; De la Fuente, 2008). The lower neopterin 
concentrations in centenarians, therefore, could suggests that a reduced activation of the aged 
immune system may might be associated with improved survival and health status. This is 
consistent with the observations that the elevation of neopterin concentrations are related to 
increased frailty (Leng et al., 2011) and decreased humoral immunity in older adults (Murr et al., 
2003) as well as to shorter residual life span of the nonagenarians (Solichova et al., 2001). 
Furthermore, higher neopterin production is also associated with an exhausted pool of antioxidants 
(Murr et al., 2009) and increased oxidation products such as lipid peroxidation, oxidized proteins, 
or DNA. Moreover, neopterin was found itself to enhance the toxic effects induced by reactive 
oxygen species (Murr et al., 1999). Theoretically, The the smaller values of neopterin in 
centenarians, along with the age-associated trend towards higher increase with age of GSH 

















lower oxidative damage of macromolecules because of the oxidative stress emerging during the 
cell-mediated immune response. This was consistent with the previous observations that extreme 
longevity is associated with a lower degree of oxidative stress than that experienced by middle-
aged adults (Paolisso et al., 1998; Barbieri et al., 2003; Alonso-Fernandez et al., 2008). Limitations 
of our study include the relatively small sample size, its cross-sectional design, and the lack of 
other measures of inflammation and oxidative stress status in our population.  
 
5. Conclusions 
In this study, we We observed, for the first time, in Sardinian centenarians a significant inversion of 
the age-associated trend to increasing neopterin concentrations in Sardinian centenarians. This 
finding suggests that immune function is a marker of health, and would suggest that plasma 
neopterin concentrations may might be a useful predictor of survival and health status. The lower 
neopterin concentrations in centenarians suggest, in fact, is consistent with the view of a reduced 
inflammation and oxidative stress status in centenarians these subjects when compared with other 
subgroups within the old-old population. However, Further as our study shows limitations 
including the relatively small sample size, its cross-sectional design, and the lack of other measures 
of inflammation and oxidative stress status in the observed population, further studies that include 
prospective investigations, however, are needed to understand the biological processes that underlie 
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Table 1. Biochemical characteristics of the 149 subjects 
Figure 1. Graphical relationship between neopterin concentrations and age with trend line 
computed by local regression smoothing method. Spearman’s coefficient of rank correlation was 
0.27 and it was significant at P=0.0008. 
Figure 2. Pairwise comparisons of subgroups according to age clusters. 60-years-old group was 
statistically different from 80-, 90-, 95-, and 100-years-old groups. 80-years-old group was 
statistically different from 60-, and 95-years-old groups. 90-years-old group was statistically 
different from 60-years-old group. 95-years-old group was statistically different from 60-, 80-, and 
100-years-old groups. 100-years-old group was statistically different from 60- and 95-years-old 
groups. Central box in the Whisker plot represents the values from the lower to upper quartile (25 
to 75 percentile) while the middle line is the median value. The lines departing from the lower and 
upper quartiles indicate the minimum and maximum value, excluding outside (inner fences) and far 
out (outer fences) values. Trend to lower neopterin concentrations in the 100-year-old cluster vs. 
the 95-year-old group was significant at P=0.024 (Jonckheere-Terpstra trend test). 
Figure 3. Trend to lower neopterin concentrations in the 100-year-old cluster vs. the 95-year-old 



































































































years, mean ±SD 
85.2±14.2 60.7±0.7 81.3±2.6 91.2±1.5 95.9±1.1 100.9±1.2 
NEO 

























































































 Lower neopterin concentrations in Sardinian centenarians is observed; 
 A reduced inflammation and oxidative stress status in centenarians are suggested;  
 Neopterin levels may serve as a marker of health in elderly; 
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